These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20572)

  • 1. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment.
    Regan PT; Malagelada JR; Dimagno EP; Go VL
    Gastroenterology; 1979 Aug; 77(2):285-9. PubMed ID: 447041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the use of cimetidine in pancreatic insufficiency.
    Regan PT; Malagelada JR; Dimagno EP; Go VL
    Mayo Clin Proc; 1978 Feb; 53(2):79-83. PubMed ID: 340805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic enzyme replacement: the effect of antacids or cimetidine.
    Graham DY
    Dig Dis Sci; 1982 Jun; 27(6):485-90. PubMed ID: 6282548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory and practice in the individualization of oral pancreatic enzyme administration for chronic pancreatitis.
    Andrén-Sandberg A
    Int J Pancreatol; 1989; 5 Suppl():51-62. PubMed ID: 2702251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to cystic fibrosis.
    de Biéville F; Neijens HJ; Fernandes J; van Caillie M; Kerrebijn KF
    Acta Paediatr Scand; 1981 Jan; 70(1):33-7. PubMed ID: 6908433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
    Graham DY
    N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancreatic enzymes--substitution preparations].
    Berndt W
    Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287
    [No Abstract]   [Full Text] [Related]  

  • 20. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.